Comisión, Europea

mAbxience anuncia la aprobación por la Comisión Europea de sus biosimilares de denosumab

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

mAbxience Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom United States of America

View original content:https://www.prnewswire.com/news-releases/mabxience-anuncia-la-aprobacion-por-la-comision-europea-de-sus-biosimilares-de-denosumab-302496771.html

en | boerse | 67972553 |